Finance

Beta
Lists
344860:KOSDAQ
InnoGene Co Ltd
₩1,337.00
+4.86%
(+62.00) 1D
Jun 30, 1:43:39 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 344860...
Open
₩1,275
High
₩1,480
Low
₩1,275
Mkt. cap
16.08B
Avg. vol.
202.27K
Volume
77.61K
Dividend
6.73%
Quarterly dividend
₩22
Ex-dividend date
Dec 29, 2025
P/E ratio
100.62
52-wk high
₩2,800
52-wk low
₩1,099
EPS
₩13
Shares outstanding
12.03M
No. of employees
58
Open
₩1,275
High
₩1,480
Low
₩1,275
Mkt. cap
16.08B
Avg. vol.
202.27K
Volume
77.61K
Dividend
6.73%
Quarterly dividend
₩22
Ex-dividend date
Dec 29, 2025
P/E ratio
100.62
52-wk high
₩2,800
52-wk low
₩1,099
EPS
₩13
Shares outstanding
12.03M
No. of employees
58
News stories
From sources across the web
About InnoGene Co Ltd
CEO-
Employees58
Founded2005
Headquarters-
SectorPersonal care products
Websiteinnogene.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.89B
2.14B
2.41B
2.59B
Cost of goods sold
442.36M
540.53M
654.68M
1.19B
Cost of revenue
442.36M
540.53M
654.68M
1.19B
Research and development expenses
59.69M
75.95M
71.34M
74.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.37B
1.48B
1.51B
1.40B
Operating expense
1.50B
1.63B
1.72B
1.58B
Total operating expenses
1.94B
2.17B
2.37B
2.77B
Operating income
-48.19M
-29.83M
39.49M
-175.98M
Other non operating income
-61.68M
30.81K
76.16M
-354.81K
EBT including unusual items
-42.06M
44.89M
174.13M
-79.56M
EBT excluding unusual items
-42.06M
44.89M
172.48M
-89.27M
Income tax expense
-14.53M
-14.48M
-36.55M
16.55M
Effective tax rate
34.54%
-32.27%
-20.99%
-20.81%
Other operating expenses
24.48M
27.58M
24.06M
26.12M
Net income
-27.54M
59.37M
210.67M
-96.11M
Net profit margin
-1.45%
2.78%
8.73%
-3.71%
Earnings per share
-
-
-
-
Interest and investment income
83.55M
66.70M
56.65M
55.44M
Interest expense
-1.06M
-1.31M
-1.04M
-809.00K
Net interest expenses
82.49M
65.39M
55.61M
54.63M
Depreciation and amortization charges
43.61M
37.49M
37.48M
37.48M
EBITDA
16.30M
28.45M
97.87M
-108.46M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer